Cite
HARVARD Citation
Hey, J. et al. (n.d.). P2‐012: Phase 1 Development of ALZ‐801, a Novel Beta Amyloid Anti‐Aggregation Prodrug of Tramiprosate with Improved Drug Properties, Supporting Bridging to The Phase 3 Program. Alzheimer's & dementia. p. P613. [Online].